REGINA ENGEL: Open Payments
NPI 1770636375 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 10 payments from 7 companies in 2025. Trend: 2023 $427 · 2024 $1,246 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Almatica Pharma LLC | 1 | $23 |
| Lundbeck LLC | 1 | $18 |
| Neos Therapeutics, LP | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: INGREZZA, REXULTI, LOREEV XR, Auvelity, ABILIFY ASIMTUFII, Sunosi, Adzenys XR-ODT, CAPLYTA.
Industry payments across OH — which companies pay providers there.
